* Adapthealth Corp AHCO.OQ AHCO.O is expected to show a
rise
in quarterly revenue when it reports results on February 27 for
the period ending December 31 2023
* The Plymouth Meeting Pennsylvania-based company is
expected to
report a 5.8% increase in revenue to $825.441 million from
$780.28 million a year ago, according to the mean estimate from
10 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Adapthealth Corp is for
earnings of 18 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Adapthealth
Corp
is $10.00, above its last closing price of $7.52.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.17 0.19 0.42 Beat 126.2
Jun. 30 2023 0.10 0.10 0.09 Missed -11.5
Mar. 31 2023 0.08 0.08 0.11 Beat 42.6
Dec. 31 2022 0.25 0.28 -0.02 Missed -107
Sep. 0.31 0.31 0.11 Missed -64.7
30 2022
Jun. 30 2022 0.25 0.26 0.09 Missed -65
Mar. 31 2022 0.19 0.18 0.08 Missed -55.6
Dec. 31 2021 0.32 0.34 0.17 Missed -50.8
This summary was machine generated February 23 at 14:44 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)